News 8 spoke with the dean of the Penn State College of Medicine about what advances are being made in the treatment of ...

University of Queensland research using natural killer cells may lead to the first new treatment for a devastating childhood ...

The intensive therapy helps children with developmental, neurological or physical challenges to progress their motor skills, ...

SAN FRANCISCO -- The pediatric Crohn's disease exclusion diet was associated with clinical remission for children with good ...

Ground was broken on the 8,300-square-foot Dorion Family Pediatric Center, which will help children deal with complex medical ...

Metronomic chemotherapy (MC) is emerging as a groundbreaking treatment for pediatric neuroblastoma, offering a more accessible and manageable option for children with high-risk and relapsed/refractory ...

is leveraging partnerships in each of its 24 communities across the country with the goal of connecting more youth with trained service and therapy dogs in schools, pediatric hospitals and after ...

has provided a positive opinion for Advanced Therapy Medicinal Product (ATMP) classification for the company's gene therapy candidate OCU400 to treat Retinitis pigmentosa. A phase 3 study of ...

Ocugen, Inc. has announced that the European Commission has given a positive opinion for the classification of its gene therapy product, OCU400, as an Advanced Therapy Medicinal Product (ATMP ...

has granted Regenerative Medicine Advanced Therapy (RMAT) designation to laru-zova (laruparetigene zovaparvovec) for the treatment of X-linked retinitis pigmentosa (XLRP). RMAT designation was ...

made strides in advancing pediatric care with the successful completion of the Pediatric Advanced Life Support (PALS) Instructor and Provider Course. A total of 13 doctors from the departments of ...

Laru-zova is a gene therapy currently being investigated for the treatment of patients with XLRP. Laru-zova expresses the full length RPGR protein, thereby addressing the full complement of ...